Advances in Na+/I− symporter (NIS) research in the thyroid and beyond
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 213 (1) , 59-70
- https://doi.org/10.1016/j.mce.2003.10.059
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Genetically targeted radiotherapy for multiple myelomaBlood, 2003
- Benign Nonfunctioning Thyroid Adenomas Are Characterized by a Defective Targeting to Cell Membrane or a Reduced Expression of the Sodium Iodide Symporter ProteinJournal of Clinical Endocrinology & Metabolism, 2002
- In vivo sodium iodide symporter gene therapy of prostate cancerGene Therapy, 2001
- Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene deliveryGene Therapy, 2000
- Regulation of the Rat Thyrotropin Receptor Gene by the Methylation-Sensitive Transcription Factor GA-Binding ProteinMolecular Endocrinology, 1998
- N-linked Glycosylation of the Thyroid Na+/I− Symporter (NIS)Journal of Biological Chemistry, 1998
- Follicular cells of the thyroid gland require Pax8 gene functionNature Genetics, 1998
- Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS)Nature Genetics, 1997
- Retinoic Acid Increases Sodium/Iodide Symporter mRNA Levels in Human Thyroid Cancer Cell Lines and Suppresses Expression of Functional Symporter in Nontransformed FRTL-5 Rat Thyroid CellsBiochemical and Biophysical Research Communications, 1997
- Cloning of the Human Sodium Iodide SymporterBiochemical and Biophysical Research Communications, 1996